Treating the kidney to cure the heart

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Global rise in chronic renal and cardiovascular diseases.
• Renal disease is a primary risk factor for cardiovascular morbidity and mortality.
• Effective strategies to slow renal disease progression are vital for cardiovascular event reduction.

Purpose of the Study:

• To review the role of renin-angiotensin system inhibition in managing chronic kidney disease (CKD).
• To discuss comprehensive strategies beyond renin-angiotensin system inhibition for improving patient outcomes.
• To highlight the urgent need for prevention strategies, especially in developing countries.

Main Methods:

• Review of large, randomized studies on renin-angiotensin system inhibitors (ACE inhibitors and ARBs).
• Analysis of evidence supporting combined interventions for CKD management.
• Examination of epidemiological trends in chronic renal and cardiovascular diseases.

Main Results:

• Renin-angiotensin system inhibition significantly reduces renal disease progression in diabetic and non-diabetic CKD patients.
• Improved renal outcomes correlate with reduced cardiovascular risk.
• A significant proportion of patients still progress to end-stage renal failure or cardiovascular death despite current treatments.

Conclusions:

• While renin-angiotensin system inhibition is effective, a multifaceted approach including blood pressure and proteinuria control, lipid management, glycemic control, and lifestyle changes is superior.
• Enhanced prevention strategies are essential to combat the growing burden of CKD and associated cardiovascular diseases.
• Developing countries face a disproportionately high and increasing incidence of these conditions, necessitating targeted interventions.